ABCAM (US) LTD

Active Cambridge

Activities of other holding companies n.e.c.

0 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.
A

ABCAM (US) LTD

Activities of other holding companies n.e.c.

Founded 20 Jul 2012 Active Cambridge, United Kingdom 0 employees website.com
Life sciences and medical technology Activities of other holding companies n.e.c.

Previous Company Names

3711TH SINGLE MEMBER SHELF TRADING COMPANY LIMITED 20 Jul 2012 — 22 Oct 2012
Accounts Submitted 30 Jul 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 21 Jul 2025 Next due 2 Aug 2026 3 months remaining
Net assets £128M £1K 2024 year on year
Total assets £128M £1K 2024 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ABCAM (US) LTD (08151375), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 20 Jul 2012. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2013–2024)

Cash in Bank

£6.00k

Increased by £1.00k (+20%)

Net Assets

£127.65M

Increased by £1.00k (+0%)

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 54,940,001 Shares £90.59m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Mar 202354,940,000£54.94m£1
23 Dec 20161£35.65m£35.65m

Officers

Officers

2 active 1 resigned
Status
Gillian Claire Louisa JohnsonDirectorBritishEngland5229 Nov 2024Active
Nicola Ann SummersDirectorBritishUnited Kingdom5629 Nov 2024Active

Shareholders

Shareholders (1)

Abcam Us Group Holdings Inc
100.0%
143,663,732

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Abcam Us Group Holdings Inc

United States Of America

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Danaher Corporation

Unknown

Active
Notified 22 May 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent

Group Structure

Group Structure

ABCAM (US) LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
12 Nov 2025Persons With Significant ControlDanaher Corporation notified as a person with significant control
12 Nov 2025Persons With Significant ControlCessation of Abcam Us Group Holdings Inc as a person with significant control on 22 May 2024
11 Nov 2025OfficersAppointment of Jonathan Peter Fogg as director on 31 Oct 2025
11 Nov 2025OfficersTermination of Nicola Ann Summers as director on 31 Oct 2025
30 Jul 2025AccountsAnnual accounts made up to 31 Dec 2024
12 Nov 2025 Persons With Significant Control

Danaher Corporation notified as a person with significant control

12 Nov 2025 Persons With Significant Control

Cessation of Abcam Us Group Holdings Inc as a person with significant control on 22 May 2024

11 Nov 2025 Officers

Appointment of Jonathan Peter Fogg as director on 31 Oct 2025

11 Nov 2025 Officers

Termination of Nicola Ann Summers as director on 31 Oct 2025

30 Jul 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Danaher Corporation notified as a person with significant control

5 months ago on 12 Nov 2025

Cessation of Abcam Us Group Holdings Inc as a person with significant control on 22 May 2024

5 months ago on 12 Nov 2025

Appointment of Jonathan Peter Fogg as director on 31 Oct 2025

5 months ago on 11 Nov 2025

Termination of Nicola Ann Summers as director on 31 Oct 2025

5 months ago on 11 Nov 2025

Annual accounts made up to 31 Dec 2024

9 months ago on 30 Jul 2025